ipscell.com
Alliance for Regenerative Medicine (ARM) Opposes REGROW Act, Risks to Patients Cited - The Niche
The biggest debate today in the stem cell world is over how much regulation is needed for new, investigational stem cell therapies that are not as yet approved. Sometimes it feels very lonely being out there publicly advocating for appropriately thorough regulation of stem cell therapies and at times I get a lot of heat for … Alliance for Regenerative Medicine (ARM) Opposes REGROW Act, Risks to Patients Cited Read More »
Professor Paul Knoepfler, Ph.D.